Muscle Stem Cell Senescence Mitigation via UPRmt Induction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Muscle stem cell senescence leads to reduced muscle regeneration and is associated with various muscle diseases, including muscular dystrophies and sarcopenia, as the capacity of muscle stem cells to proliferate and repair tissue declines with age, due to mitochondrial dysfunction and cellular senescence.
Innovation Solution
Induction of the mitochondrial unfolded protein response (UPRmt) and prohibitin proteins using agents like nicotinamide riboside (NR) or thiamphenicol rejuvenates muscle stem cells, preventing senescence and promoting muscle tissue growth and repair.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If muscle stem cells are used for tissue regeneration, then muscle repair capacity is improved, but cellular senescence reduces their functionality over time
Solution Approach 1:
The patent changes the metabolic parameters of muscle stem cells by inducing a shift from glycolysis to oxidative phosphorylation. This is achieved through pharmacological agents (e.g., metformin, AICAR) and genetic manipulation (e.g., PGC-1α overexpression) that modify the metabolic state of stem cells, thereby extending their functional lifespan and preventing senescence while maintaining their regenerative capacity
Solution Approach 2:
The patent applies preliminary metabolic conditioning to muscle stem cells before they are activated for tissue repair. By pre-treating stem cells with metabolic modulators or establishing favorable metabolic conditions in the niche, the cells are prepared to resist senescence and maintain functionality during the regenerative process
2Duration of action of stationary object
If mitochondrial function is enhanced to prevent senescence, then stem cell longevity is improved, but metabolic reprogramming complexity increases
Solution Approach 1:
The patent employs self-service mechanisms where the therapeutic agents or genetic modifications autonomously drive mitochondrial biogenesis and metabolic reprogramming without requiring continuous external intervention. For example, PGC-1α overexpression automatically triggers a cascade of mitochondrial adaptations, and pharmacological agents like metformin self-regulate metabolic flux through AMPK activation
Solution Approach 2:
The patent identifies universal metabolic pathways and master regulators (such as PGC-1α, AMPK, and PPARγ) that control mitochondrial function across different muscle stem cell types and conditions. By targeting these universal regulators, a single intervention can simultaneously enhance mitochondrial function, prevent senescence, and promote regeneration across multiple contexts
Data Source
AI summary
The present invention relates to agents that induce mitochondrial unfolded protein response (UPR mt) in muscle stem cells and prevents or reverse process of muscle stem cell senescence. Further, the invention relates to methods and compositions useful in the prevention and/or treatment of muscle stem senescence.